LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. "We are thrilled to have Paul assume the role of Chief Executive Officer," said Pulse Biosciences’ Co-Chairman of the ...

Pulse Biosciences has appointed the company's co-chairman, Paul A. LaViolette, as its new chief executive. LaViolette replaces Burke T. Barrett, who was named president and CEO of the medical ...

Pulse Biosciences (PLSE) announced the appointment of Paul LaViolette, current co-chairman of the board, as CEO. LaViolette is currently a director for Edwards Lifesciences (EW) and chairman of ...

Pulse Biosciences (Nasaq:PLSE) announced today that it appointed Jon Skinner as CFO, effective Feb. 3, 2025.

Pulse Biosciences (PLSE) announced the appointment of Jon Skinner as Chief Financial Officer, effective February 3. “I am excited to announce ...

(RTTNews) - Novel bioelectric medicine company Pulse Biosciences, Inc. (PLSE) announced Friday the appointment of Paul LaViolette, current Co-Chairman of the Board, as Chief Executive Officer.

today announced the appointment of Paul A. LaViolette, current Co-Chairman of the Board, as Chief Executive Officer.

LaViolette, current Co-Chairman of the Board, as Chief Executive Officer. "We are thrilled to have Paul assume the role of Chief Executive Officer," said Pulse Biosciences’ Co-Chairman of the Board ...